HDAX Therapeutics
16 posts
@HDAXtx
Tackling unmet healthcare needs, with a focus on safety and tolerability in patients.
We are pleased to announce the six emerging startups chosen to participate in the #MassBioDrive Fall 2022 Cohort: AdductNE, @HDAXtx, @HybridexBio, Jenthera Therapeutics Inc., Orion, and pacDNA massbio.org/innovation-ser…
We're excited to welcome @ABOzymes, Cura Therapeutics, Damona pharma & @HDAXtx, the companies selected to present at our Emerging Co.'s Forum at @BIOTECanada's upcoming Investor Summit. adMare is all about building companies, and these 4 are ones to watch!admarebio.com
The #BioTEC2021 pitch competition was a huge success! Thank you to the pitch competition teams, panel of VC judges, industry mentors, and sponsors! * 1st: Epiloid * 2nd: @HDAXtx * 3rd: Vope Medical * Therapeutics focus award: @HDAXtx * People’s choice: @vope_ai
H2i Newsletter: Congratulations Pitch Perfect Winners! - mailchi.mp/0308756ec76c/h…
Thank you @SweetPharmaDay for amazing sessions today, and honored to have been named 2021 best presentation at this invitation-only life sciences event!
We are proud to announce the winner of @SweetPharmaDay 2021. Congratulations to Nabanita Nawar from HDAX Therapeutics for your great presentation! HDAX receives $2500 and memberships to @BIO_Qc and @BIOTECanada
Meet L2M Toronto's Summer 2021 Cohort! Delivered by @RyersonU, 23 talented teams from 8 universities will be embarking on their entrepreneurial journey. Read about the diverse cohort here: buff.ly/3tWW5pQ Thank you to the Government of Canada + Mitacs for the support.
At #MedicinebyDesign’s Building a Biotech Venture Pitch Competition, HDAX Therapeutics (@Patrick_Gunning lab) was chosen to receive $25,000 in funding for their #regenmed concept, a small molecule therapy that could have an impact on Alzheimer's disease ➡️mbd.utoronto.ca/news/hdax-ther…
